Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Betamethasone vs Dextrose Injections for Trigger Finger

Official title: Comparison of Ultrasound-Guided Betamethasone and Dextrose Injections in the Treatment of Trigger Finger: A Randomized Controlled Trial

Run by Istanbul University - Cerrahpasa · NCT07681804 · Data updated 2026-11-12

This trial tests whether an ultrasound-guided betamethasone shot works better than a dextrose injection for people with trigger finger.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment42 (estimated)
SponsorIstanbul University - Cerrahpasa
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedJune 30, 2026
Main results expectedApril 2027
Study endsMay 2027
Registry record updatedJuly 28, 2026
Trial IDNCT07681804 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 with clinically diagnosed trigger finger lasting at least four weeks and no recent finger injections or surgery.

Probably not a fit

Patients with conditions or therapies that confound outcomes or who have exclusion criteria (e.g., active infection, uncontrolled diabetes or hypertension) may not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two ultrasound-guided injections for trigger finger: betamethasone, a corticosteroid, and a dextrose solution. Participants aged 18 to 75 with symptoms for at least four weeks are assigned to receive one of the injections with lidocaine under sterile conditions. The study measures pain on the Numeric Rating Scale as the primary outcome, with secondary outcomes including triggering severity, hand function, grip and pinch strength, and fine motor skills over a 12-week follow-up. The aim is to determine which injection provides greater symptom relief and functional improvement in this condition.

Why it matters

Potential benefit: If successful, the preferred injection could provide better pain relief and hand function with potentially fewer adverse effects.

How similar studies have gone: Previous corticosteroid injections are commonly effective for trigger finger, while evidence for dextrose is limited; this head-to-head trial addresses a gap in comparative data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 75 years
* Clinical diagnosis of trigger finger
* Presence of symptoms for at least 4 weeks

Exclusion Criteria:

* Previous surgery on the affected finger
* Injection treatment to the affected finger within the previous 3 months
* Active local or systemic infection
* Active malignancy
* Active inflammatory rheumatic disease (e.g., rheumatoid arthritis, ankylosing spondylitis, polymyalgia rheumatica, vasculitis)
* Uncontrolled diabetes mellitus and/or uncontrolled hypertension
* Autoimmune connective tissue diseases (e.g., systemic lupus erythematosus, antiphospholipid syndrome, systemic sclerosis, Sjögren syndrome, polymyositis, dermatomyositis, adult-onset Still's disease)
* Coagulopathy that increases the risk of injection procedures
* Pregnancy
* Known allergy or hypersensitivity to lidocaine, betamethasone, or dextrose
* Mental impairment or severe psychiatric disorder that may interfere with study participation or informed consent

Where it's running

  • Istanbul University - Cerrahpasa, Cerrahpasa Faculty of Medicine
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.